QA: Onconetix Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001782107_2024_Onconetix_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001782107, Onconetix Inc

  xvar xval
0 AssetsCurrent 5,838,271
1 IntangibleAssetsNetIncludingGoodwill 81,087,029
2 PropertyPlantAndEquipmentNet 60,654
3 remainder_Assets 532,078
4 LiabilitiesCurrent 17,190,247
5 LiabilitiesNoncurrent 74,290
6 remainder_Liabilities 4,612,934
7 CostOfGoodsAndServicesSold 1,185,630
8 SellingGeneralAndAdministrativeExpense 14,770,678
9 ResearchAndDevelopmentExpense 1,949,406
10 remainder_Expenses 18,174,753
11 remainder_Revenues 58,465
12 remainder_NetIncome -1,387,692
13 remainder_ComprehensiveNetIncome 2,380,920
  yvar yval
0 Assets 87,518,032
1 Liabilities 21,877,471
2 Expenses 36,080,467
3 Revenues 58,465
4 StockholdersEquity 65,640,561
5 NetIncome -37,409,694
6 ComprehensiveNetIncome -36,219,234
7 BaseVar 74,651,524
8 EconomicCapitalRatiobeforeLimitedLiability 1.95
9 EconomicCapitalRatio 2.99

Edgar->Model Mapping

Feature Distribution

Change over Time